subscribe
 

Faster access to high affinity antibody drug candidates

MorphoSys AG has unveiled a multi-year technology development programme which will lead to a significantly enhanced version of its antibody generation platform.



Subscribe

Subscribe



Newsbrief

Twitter Icon © Setform Limited
subscribe